Tuberculosis (TB) continues to be a global health crisis, with an estimated 10 million people developing the disease in 2019 according to the World Health Organization. Rapid and accurate diagnosis is fundamental to combat this deadly disease. This article provides an overview of current diagnostic approaches in healthcare.
Microbiological testing remains the gold standard for TB diagnosis. This includes smear microscopy, culture methods, and nucleic acid amplification testing (NAAT). While smear microscopy is inexpensive and quick, it lacks sensitivity. Culture methods are more sensitive but can take weeks to yield results. NAAT, such as the Xpert MTB/RIF assay, offers both sensitivity and speed, but at a higher cost.
Imaging techniques like chest radiography and computed tomography (CT) scans play a vital role in TB diagnosis. They provide visual evidence of disease, helping in the detection of pulmonary TB and its extra-pulmonary manifestations. However, these methods are not definitive as other diseases can mimic TB on imaging.
The Tuberculin Skin Test (TST) and Interferon Gamma Release Assay (IGRA) are used to detect latent TB infection. Both tests measure the immune response to TB antigens. The choice between TST and IGRA depends on various factors including cost, availability, and the patient's age and immune status.
Emerging diagnostic methods include next-generation sequencing, breath tests, and point-of-care tests. These novel techniques promise to improve TB diagnosis by offering rapid, accurate, and patient-friendly options. However, they are still in the experimental or early implementation stages.
In conclusion, the diagnosis of TB involves a combination of microbiological tests, imaging techniques, and immunological assays. Novel diagnostic methods hold promise for the future. However, their adoption in routine clinical practice will depend on further research and cost-effectiveness analysis.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation